Literature DB >> 11551881

Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice.

M Scherrer-Crosbie1, R Ullrich, K D Bloch, H Nakajima, B Nasseri, H T Aretz, M L Lindsey, A C Vançon, P L Huang, R T Lee, W M Zapol, M H Picard.   

Abstract

Background- To investigate the role of endothelial nitric oxide synthase (NOS3) in left ventricular (LV) remodeling after myocardial infarction (MI), the impact of left anterior descending coronary artery ligation on LV size and function was compared in 2- to 4-month-old wild-type (WT) and NOS3-deficient mice (NOS3(-/-)). Methods and Results- Two days after MI, both strains of mice had a similar LV size, fractional shortening, and ejection fraction by echocardiography. Twenty-eight days after MI, both strains had dilated LVs with decreased fractional shortening and lower ejection fractions. Although the infarcted fraction of the LV was similar in both strains, LV end-diastolic internal diameter, end-diastolic volume, and mass were greater, but fractional shortening, ejection fraction, and the maximum rate of developed LV pressure (dP/dt(max)) were lower in NOS3(-/-) than in WT mice. Impairment of diastolic function, as measured by the time constant of isovolumic relaxation (tau) and the maximum rate of LV pressure decay (dP/dt(min)), was more marked in NOS3(-/-) than in WT mice. Mortality after MI was greater in NOS3(-/-) than in WT mice. Long-term administration of hydralazine normalized blood pressure in NOS3(-/-) mice, but it did not prevent the LV dilatation, impaired systolic and diastolic function, and increased LV mass that followed MI. In WT mice, capillary density and myocyte width in the nonischemic portion of the LV did not differ before and 28 days after MI, whereas in NOS3(-/-) mice, capillary density decreased and myocyte width increased after MI, whether or not hydralazine was administered. Conclusions- These results suggest that the presence of NOS3 limits LV dysfunction and remodeling in a murine model of MI by an afterload-independent mechanism, in part by decreasing myocyte hypertrophy in the remote myocardium.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11551881     DOI: 10.1161/hc3601.094298

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  94 in total

Review 1.  Nitric oxide, cell death, and heart failure.

Authors:  Jun-ichi Oyama; Stefan Frantz; Charles Blais; Ralph A Kelly; Todd Bourcier
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

2.  Brown adipose tissue blood flow and mass in obesity: a contrast ultrasound study in mice.

Authors:  Maëva Clerte; David M Baron; Peter Brouckaert; Laura Ernande; Michael J Raher; Aidan W Flynn; Michael H Picard; Kenneth D Bloch; Emmanuel S Buys; Marielle Scherrer-Crosbie
Journal:  J Am Soc Echocardiogr       Date:  2013-08-28       Impact factor: 5.251

Review 3.  Nitric oxide synthases in the pathogenesis of cardiovascular disease: lessons from genetically modified mice.

Authors:  Hiroaki Shimokawa; Masato Tsutsui
Journal:  Pflugers Arch       Date:  2010-02-24       Impact factor: 3.657

Review 4.  Race-related differences in heart failure therapies: simply black and white or shades of grey?

Authors:  Gautam R Shroff; Anne L Taylor; Monica Colvin-Adams
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

Review 5.  Cardioprotective actions of cyclic GMP: lessons from genetic animal models.

Authors:  Christian F Deschepper
Journal:  Hypertension       Date:  2009-12-14       Impact factor: 10.190

Review 6.  Redox signaling in cardiovascular health and disease.

Authors:  Nageswara R Madamanchi; Marschall S Runge
Journal:  Free Radic Biol Med       Date:  2013-04-11       Impact factor: 7.376

7.  Inhibition of MAPK signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through reduction of inflammation.

Authors:  Lei-Lei Chen; Tie Bin Zhu; Hang Yin; Jun Huang; Lian Sheng Wang; Ke Jiang Cao; Zhi Jian Yang
Journal:  Mol Biol Rep       Date:  2009-11-12       Impact factor: 2.316

8.  Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.

Authors:  Beate Fiedler; Suzanne M Lohmann; Albert Smolenski; Stephan Linnemuller; Burkert Pieske; Frank Schroder; Jeffery D Molkentin; Helmut Drexler; Kai C Wollert
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

9.  Impaired flow-mediated vasodilatation is associated with increased left ventricular mass in a multiethnic population. The Northern Manhattan Study.

Authors:  Takuya Hasegawa; Bernadette Boden-Albala; Kazuo Eguchi; Zhezhen Jin; Ralph L Sacco; Shunichi Homma; Marco R Di Tullio
Journal:  Am J Hypertens       Date:  2010-01-07       Impact factor: 2.689

10.  Akt/FOXO3a/SIRT1-mediated cardioprotection by n-tyrosol against ischemic stress in rat in vivo model of myocardial infarction: switching gears toward survival and longevity.

Authors:  Samson Mathews Samuel; Mahesh Thirunavukkarasu; Suresh Varma Penumathsa; Debayon Paul; Nilanjana Maulik
Journal:  J Agric Food Chem       Date:  2008-10-01       Impact factor: 5.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.